GeneFerm Biotechnology Co Ltd

ROCO:1796 (Taiwan)  
NT$ 61.00 (+0.83%) Jun 19
29.61
P/B:
3.16
Market Cap:
NT$ 2.53B ($ 78.17M)
Enterprise V:
NT$ 2.55B ($ 78.88M)
Volume:
53.00K
Avg Vol (2M):
77.21K
Trade In:
Volume:
53.00K
Avg Vol (2M):
77.21K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for GeneFerm Biotechnology Co Ltd ( ) from 2016 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. GeneFerm Biotechnology stock (ROCO:1796) PE ratio as of Jun 20 2024 is 29.61. More Details

GeneFerm Biotechnology Co Ltd (ROCO:1796) PE Ratio (TTM) Chart

To

GeneFerm Biotechnology Co Ltd (ROCO:1796) PE Ratio (TTM) Historical Data

Total 1223
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
GeneFerm Biotechnology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-20 29.6 2024-04-16 27.6
2024-06-19 29.6 2024-04-15 29.2
2024-06-18 29.4 2024-04-12 29.8
2024-06-17 29.3 2024-04-11 30.4
2024-06-14 29.1 2024-04-10 30.3
2024-06-13 29.3 2024-04-09 30.2
2024-06-12 29.0 2024-04-08 30.7
2024-06-11 28.9 2024-04-03 32.2
2024-06-07 30.6 2024-04-02 33.4
2024-06-06 30.7 2024-04-01 33.0
2024-06-05 30.7 2024-03-29 31.4
2024-06-04 30.6 2024-03-28 32.5
2024-06-03 30.4 2024-03-27 20.4
2024-05-31 30.2 2024-03-26 18.5
2024-05-30 30.1 2024-03-25 18.1
2024-05-29 31.0 2024-03-22 18.1
2024-05-28 31.0 2024-03-21 18.4
2024-05-27 31.1 2024-03-20 18.5
2024-05-24 31.3 2024-03-19 18.8
2024-05-23 30.9 2024-03-18 19.0
2024-05-22 30.8 2024-03-15 19.0
2024-05-21 31.2 2024-03-14 18.7
2024-05-20 32.1 2024-03-13 18.8
2024-05-17 30.5 2024-03-12 19.0
2024-05-16 27.8 2024-03-11 18.8
2024-05-15 27.1 2024-03-08 19.7
2024-05-14 27.0 2024-03-07 19.8
2024-05-13 26.7 2024-03-06 20.0
2024-05-10 26.8 2024-03-05 20.1
2024-05-09 27.3 2024-03-04 20.1
2024-05-08 26.8 2024-03-01 20.2
2024-05-07 26.6 2024-02-29 20.0
2024-05-06 26.6 2024-02-28 20.0
2024-05-03 26.6 2024-02-27 20.0
2024-05-02 26.8 2024-02-26 20.2
2024-04-30 26.8 2024-02-23 20.5
2024-04-29 27.2 2024-02-22 20.7
2024-04-26 27.1 2024-02-21 21.0
2024-04-25 26.8 2024-02-20 21.3
2024-04-24 26.8 2024-02-19 21.4
2024-04-23 26.8 2024-02-16 20.6
2024-04-22 26.6 2024-02-15 19.6
2024-04-19 26.6 2024-02-14 20.6
2024-04-18 28.1 2024-02-13 20.6
2024-04-17 27.9 2024-02-12 20.6

GeneFerm Biotechnology Co Ltd (ROCO:1796) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
GeneFerm Biotechnology Co Ltd is a fermentation company based in Taiwan. It is engaged in manufacturing health food and supplements which include Fermented Microbial products, Fermented Fungi products, Probiotics and Extraction, and Concentration products among others.